ArticleBreast cancer research : BCR2008

Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer.

Giuseppe Cancello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.